drug

povorcitinib

1 story · latest Jul 28, 2026

Status: Investigational
Codes: INCB054707, INCB54707
Trials: 5 registered trials in coverage

Relationships

Developed by Incyte Corporation

Timeline

Incyte raises 2026 sales guidance, adds ten data readouts, closes Vega deal

Jul 28Quarterly updateIncyte Corporation

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.